Evaluation of the effect of Unani formulation in knee joints pai
Phase 2
- Conditions
- Health Condition 1: M179- Osteoarthritis of knee, unspecified
- Registration Number
- CTRI/2021/01/030326
- Lead Sponsor
- uqman Unani Medical College Hospital and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of both gender
Between the age group of 40 to 70 years
Clinically and radiologically diagnosed cases of primary osteoarthritis (one or both knee joints)
Exclusion Criteria
Other types of arthritis like rheumatoid arthritis and rheumatic arthritis etc
Any systemic disease like diabetes mellitus malignancy etc
Secondary knee OA
Use of NSAIDs before baseline data
Use of intra-articular or Oral corticosteroids within 3weeks prior to baseline visit
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Knee osteoarthritis outcome score (KOOSTimepoint: At baseline and after the study <br/ ><br>
- Secondary Outcome Measures
Name Time Method Knee Joints Pain on VAS Scale <br/ ><br>Timepoint: At baseline, 15th day, and after treatment